SK92697A3 - Bicyclicly condensed pyridines, producing method, pharmaceutical compositions containing the same and their use - Google Patents

Bicyclicly condensed pyridines, producing method, pharmaceutical compositions containing the same and their use Download PDF

Info

Publication number
SK92697A3
SK92697A3 SK926-97A SK92697A SK92697A3 SK 92697 A3 SK92697 A3 SK 92697A3 SK 92697 A SK92697 A SK 92697A SK 92697 A3 SK92697 A3 SK 92697A3
Authority
SK
Slovakia
Prior art keywords
group
carbon atoms
straight
trifluoromethyl
formula
Prior art date
Application number
SK926-97A
Other languages
English (en)
Slovak (sk)
Inventor
Arndt Brandes
Michael Logers
Gunter Schmidt
Rolf Angerbauer
Carsten Schmeck
Klaus-Dieter Bremm
Hilmar Bischoff
Delf Schmidt
Joachim Schumacher
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK92697A3 publication Critical patent/SK92697A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK926-97A 1996-07-08 1997-07-07 Bicyclicly condensed pyridines, producing method, pharmaceutical compositions containing the same and their use SK92697A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19627430A DE19627430A1 (de) 1996-07-08 1996-07-08 Bicyclisch kondensierte Pyridine

Publications (1)

Publication Number Publication Date
SK92697A3 true SK92697A3 (en) 1998-02-04

Family

ID=7799218

Family Applications (1)

Application Number Title Priority Date Filing Date
SK926-97A SK92697A3 (en) 1996-07-08 1997-07-07 Bicyclicly condensed pyridines, producing method, pharmaceutical compositions containing the same and their use

Country Status (30)

Country Link
US (1) US6063788A (sh)
EP (1) EP0825185A1 (sh)
JP (1) JPH1067751A (sh)
KR (1) KR980009247A (sh)
CN (1) CN1172803A (sh)
AR (1) AR007716A1 (sh)
AU (1) AU722365B2 (sh)
BG (1) BG61972B1 (sh)
BR (1) BR9703886A (sh)
CA (1) CA2209609A1 (sh)
CO (1) CO4870759A1 (sh)
CZ (1) CZ214797A3 (sh)
DE (1) DE19627430A1 (sh)
EE (1) EE9700151A (sh)
HN (1) HN1997000082A (sh)
HR (1) HRP970331A2 (sh)
HU (1) HUP9701158A1 (sh)
ID (1) ID17659A (sh)
IL (1) IL121235A0 (sh)
MA (1) MA24261A1 (sh)
NO (1) NO308738B1 (sh)
NZ (1) NZ328260A (sh)
PE (1) PE87798A1 (sh)
PL (1) PL320954A1 (sh)
SG (1) SG46782A1 (sh)
SK (1) SK92697A3 (sh)
TN (1) TNSN97116A1 (sh)
TR (1) TR199700583A2 (sh)
YU (1) YU28897A (sh)
ZA (1) ZA976021B (sh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6462091B1 (en) 1998-12-23 2002-10-08 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications
CZ20012345A3 (cs) 1998-12-23 2001-12-12 G. D. Searle Llc Corporate Patent Department Kombinace inhibitorů transportu kyčelní ľlučové kyseliny a činidel pro sekvenci ľlučové kyseliny pro kardiovaskulární indikace
CA2356157C (en) 1998-12-23 2008-04-01 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
EP1140185B1 (en) 1998-12-23 2003-06-04 G.D. Searle LLC. Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
DK1140184T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferproteinhæmmere og nikotinsyrederivater til hjertekar indikationer
DK1140188T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af ileale galdesyretransporthæmmere og cholesterylestere tranferproteinhæmmere til cardiovaskulære indikationer
HUP0104793A2 (en) 1998-12-23 2002-06-29 Searle Llc Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6924313B1 (en) 1999-09-23 2005-08-02 Pfizer Inc. Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6544974B2 (en) 1999-09-23 2003-04-08 G.D. Searle & Co. (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
US6794544B2 (en) 2000-03-10 2004-09-21 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
US20040219619A1 (en) * 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
US6903109B2 (en) * 2001-04-18 2005-06-07 Ortho-Muniel Pharmaceutical, Inc. Arylindenopyridines and related therapeutic and prophylactic methods
US20050239782A1 (en) * 2001-04-18 2005-10-27 Heintzelman Geoffrey R Arylindenopyridines and related therapeutic and prophylactic methods
US6958328B2 (en) * 2001-04-18 2005-10-25 Ortho-Mcneil Pharmaceutical, Inc Arylindenopyridines and related therapeutic and prophylactic methods
KR100759635B1 (ko) 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 비정질 약물의 흡착체의 약학 조성물
DE60233874D1 (de) 2001-06-22 2009-11-12 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
CA2464685A1 (en) 2001-11-02 2003-05-15 G.D. Searle Llc Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
AU2003207431A1 (en) 2002-01-17 2003-09-02 Pharmacia Corporation Novel alkyl/aryl hydroxy or keto thiepines.
CA2474838C (en) * 2002-02-01 2009-01-06 Pfizer Products Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
US20040127510A1 (en) * 2002-04-16 2004-07-01 Heintzelman Geoffrey R. Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
WO2005011635A2 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
CA2554982A1 (en) 2003-09-26 2005-04-07 Japan Tobacco Inc. Method of inhibiting remnant lipoprotein production
ATE442358T1 (de) 2003-10-08 2009-09-15 Lilly Co Eli Verbindungen und verfahren zur behandlung von dyslipidemie
WO2005097806A1 (en) 2004-03-26 2005-10-20 Eli Lilly And Company Compounds and methods for treating dyslipidemia
KR20070090248A (ko) * 2004-12-18 2007-09-05 바이엘 헬스케어 아게 4-시클로알킬-치환된 테트라히드로퀴놀린 유도체 및 그의약제로서의 용도
US8617604B2 (en) 2005-02-03 2013-12-31 Bend Research, Inc. Pharmaceutical compositions with enhanced performance
JP2009512715A (ja) 2005-10-21 2009-03-26 ノバルティス アクチエンゲゼルシャフト レニン阻害剤と抗異脂肪血症剤および／または抗肥満症剤の組み合わせ
DE102006012548A1 (de) * 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
PA8801401A1 (es) * 2007-10-25 2009-05-15 Janssen Pharmaceutica Nv Arilindenopirimidinas y su uso como adenosina a2a
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
NO177005C (no) * 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
ZA911046B (en) * 1990-02-26 1992-10-28 Squibb & Sons Inc Quinoline and pyridine anchors for hmg-coa reductase inhibitors
JPH059179A (ja) * 1990-09-27 1993-01-19 Takeda Chem Ind Ltd 複素環化合物、その製造法及びａｃａｔ阻害剤

Also Published As

Publication number Publication date
HN1997000082A (es) 1997-12-26
NO973144D0 (no) 1997-07-07
BR9703886A (pt) 1998-11-03
AR007716A1 (es) 1999-11-10
TR199700583A2 (xx) 1998-01-21
DE19627430A1 (de) 1998-01-15
NO308738B1 (no) 2000-10-23
AU722365B2 (en) 2000-08-03
CO4870759A1 (es) 1999-12-27
AU2844897A (en) 1998-01-15
SG46782A1 (en) 1998-02-20
NZ328260A (en) 1998-09-24
NO973144L (no) 1998-01-09
ID17659A (id) 1998-01-15
EE9700151A (et) 1998-02-16
ZA976021B (en) 1998-02-02
MA24261A1 (fr) 1998-04-01
CN1172803A (zh) 1998-02-11
CZ214797A3 (cs) 1998-01-14
US6063788A (en) 2000-05-16
HUP9701158A1 (hu) 1999-09-28
CA2209609A1 (en) 1998-01-08
BG61972B1 (bg) 1998-11-30
PL320954A1 (en) 1998-01-19
EP0825185A1 (de) 1998-02-25
YU28897A (sh) 2000-03-21
PE87798A1 (es) 1999-02-13
HRP970331A2 (en) 1998-08-31
KR980009247A (ko) 1998-04-30
JPH1067751A (ja) 1998-03-10
IL121235A0 (en) 1998-01-04
TNSN97116A1 (fr) 2005-03-15
BG101746A (en) 1998-03-31
HU9701158D0 (en) 1997-09-29

Similar Documents

Publication Publication Date Title
SK92697A3 (en) Bicyclicly condensed pyridines, producing method, pharmaceutical compositions containing the same and their use
CA2209825C (en) Heterocyclic-fused pyridines
SK92797A3 (en) Cycloalkanopyridines, method of their producing, pharmaceutical compositions containing the same and their use
US6291477B1 (en) Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia
SK36197A3 (en) 2-arylsubstituted pyridines, process for production thereof, their use and drugs containing the same
SK31793A3 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines and piperazines and compositions and methods of use thereof
EP0482939A1 (en) Isoquinolinone derivative
EP1828137B1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
US6121330A (en) 5-Hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia
AU730109B2 (en) 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia
US4975431A (en) Certain anti-inflammatory cyclohepta[b]pyridines and analogs thereof
IE911553A1 (en) Azabenzimidazoles in the treatment of asthma, arthritis and¹related diseases
CA2085687A1 (en) New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs
EP1032559B1 (en) Aminoalkylphenol derivatives for treating depression and memory dysfunction
US5059607A (en) Imidazolyl benzisoquinolines useful as 5-ht3 receptor antagonists
NZ190834A (en) Trans-dl-5-(alkyl or allyl)-4,4a,5,6,7,8,8a,9-octahydro-21 + pyrrolo(3,4-g)quinolines,
JPH0341458B2 (sh)
DE19832159A1 (de) Substituierte Tetrahydro-naphthaline
US5929087A (en) Decahydroquinoline-based anti-cholinergic agents
MXPA97005093A (en) Bicicli condensed pyridine
DE102004061002A1 (de) Chemische Verbindung und ihre Verwendung
DE102004060997A1 (de) Chemische Verbindung und ihre Verwendung
DE102004061000A1 (de) Chemische Verbindung und ihre Verwendung
DE102004060998A1 (de) Chemische Verbindung und ihre Verwendung